How to Interpret Urine Albumin-to-Creatinine Ratio (UACR) in Diabetes
Use a spot urine albumin-to-creatinine ratio (UACR) from a first morning void specimen, and interpret values as follows: <30 mg/g is normal, 30-299 mg/g indicates moderately increased albuminuria (formerly "microalbuminuria"), and ≥300 mg/g indicates severely increased albuminuria (formerly "macroalbuminuria"). 1, 2
Collection Method
- Obtain a first morning void urine sample for optimal accuracy 1
- If a first morning sample is difficult to obtain, collect at the same time of day consistently, ensuring the patient is well-hydrated and has not eaten within 2 hours or exercised 1
- Never use timed or 24-hour collections in clinical practice—these are burdensome and add no predictive value 3, 1
Interpretation Categories
The current KDIGO classification system (adopted by ADA in 2023) defines three categories 2:
- A1 (Normal to Mildly Increased): <30 mg/g (<3 mg/mmol)
- A2 (Moderately Increased): 30-299 mg/g (3-29 mg/mmol)
- A3 (Severely Increased): ≥300 mg/g (≥30 mg/mmol)
The older terms "microalbuminuria" and "macroalbuminuria" are no longer recommended since albuminuria exists on a continuum 4.
Confirmation Requirements
Do not act on a single elevated value. To diagnose persistent albuminuria:
- Confirm values >30 mg/g with 2 of 3 specimens collected within 3-6 months 3, 5, 3
- This confirmation step is critical because UACR demonstrates high within-individual variability (coefficient of variation ~49%) 6
Factors That Cause False Elevations
Avoid testing or repeat later if the patient has 5, 7, 8:
- Vigorous exercise within 24 hours
- Active urinary tract infection
- Fever
- Congestive heart failure
- Marked hyperglycemia or hypertension
- Menstruation
- Gross hematuria
Clinical Significance by Level
A2 (30-299 mg/g):
- Early indicator of diabetic kidney disease in type 1 diabetes 4
- Marker for development of diabetic kidney disease in type 2 diabetes 4
- Well-established marker of increased cardiovascular disease risk 5, 4
- Consider ACE inhibitor or ARB therapy 4
- Note: Up to 40% may experience spontaneous remission 4
A3 (≥300 mg/g):
- Indicates established diabetic kidney disease
- High likelihood of progression to end-stage renal disease over years 5
- ACE inhibitor or ARB therapy is strongly recommended 4
Risk Stratification
UACR is a continuous risk marker—even values within the "normal" range (<30 mg/g) correlate with cardiovascular outcomes and mortality 9, 10. Higher values within any category indicate progressively greater risk 2, 7.
Monitoring Frequency
- Annual testing for all patients with type 2 diabetes (starting at diagnosis) and type 1 diabetes (starting 5 years after diagnosis) 1
- Every 6 months if UACR >30 mg/g or eGFR <60 mL/min/1.73 m² to assess treatment response and disease progression 1
- A sustained ≥30% reduction in UACR is considered a meaningful treatment response 2
Common Pitfalls
- Relying on a single measurement: The high day-to-day variability means one value can be misleading 6
- Using albumin concentration alone without creatinine correction: This is susceptible to false results from hydration status 7, 8
- Ignoring body weight in obese patients: In patients with BMI ≥28.5 kg/m², UACR may underestimate true daily albuminuria and requires body weight correction 11
- Testing during acute illness or after exercise: These transiently elevate UACR 5, 7
Integration with eGFR
Always assess both UACR and eGFR together to properly stage chronic kidney disease and guide treatment decisions 2, 12. The combination provides superior risk stratification for both kidney disease progression and cardiovascular events compared to either measure alone.